John Townsend - 21 Nov 2022 Form 4 Insider Report for Unicycive Therapeutics, Inc. (UNCY)

Role
Chief Financial Officer
Signature
/s/ John Townsend
Issuer symbol
UNCY
Transactions as of
21 Nov 2022
Net transactions value
$0
Form type
4
Filing time
23 Nov 2022, 07:00:21 UTC
Previous filing
26 Jul 2021
Next filing
30 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UNCY Stock Options Award $0 +35,000 +84% $0.000000 76,861 21 Nov 2022 Common Stock 35,000 $0.7500 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 8,750 of the stock options vest on first anniversary of the date of grant and 1/36th of the remaining options vest at the end of each successive month thereafter.